PENG Block vs. ESP Block for Pediatric Hip Surgery
Hip Dysplasia, Hip Injuries, Hip Fractures
About this trial
This is an interventional treatment trial for Hip Dysplasia
Eligibility Criteria
Inclusion Criteria: - pediatric patients aged between 0-12 years who will undergo hip surgery Exclusion Criteria: a history of chronic pain use of gabapentin/pregabalin for > 3 months opioid use > 1 repeated opioid prescription in the last three months morbid obesity (BMI > 99th percentile) Infection at block application area coagulopathy
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
Control group
Pericapsular nerve group block (PENG) group
Erector Spinae Plane Block (ESPB) group
regional anesthesia: spinal anesthesia - 0,1ml/kg 0,5% ropivacaine
regional anesthesia: spinal anesthesia - 0,1ml/kg 0,5% ropivacaine + PENG block - 0.5mL/kg 0.2% ropivacaine, max. 20mL
regional anesthesia: spinal anesthesia - 0,1ml/kg 0,5% ropivacaine + ESP block - 0.5mL/kg 0.2% ropivacaine, max. 20mL